PetMed Express operates as an online pet pharmacy offering prescription and non-prescription medications, health products, and supplies for dogs, cats, and horses across the United States. The company's product portfolio includes prescription medications such as heartworm preventatives, flea and tick preventatives, arthritis treatments, dermatitis therapies, and specialty medications for conditions including thyroid disorders, diabetes, and heart/blood pressure management. Non-prescription offerings encompass flea and tick control products, bone and joint care items, vitamins, treats, nutritional supplements, hygiene products, and general household pet supplies. The company also stocks pet food, beds, crates, stairs, and related accessories.
The company distributes its products through multiple channels including its internet website, mobile application, customer support center, and direct mail marketing. This multi-channel approach allows customers to purchase medications and supplies through their preferred platforms. PetMed Express was incorporated in 1996 and maintains its headquarters in Delray Beach, Florida. The company operates with 173 full-time employees and maintains a market capitalization of $0.1 billion. Its distribution model is primarily domestic, focusing on the U.S. pet owner market.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.30 | $-0.30 | +18.9% | |
| 2024 | $-0.37 | $-0.37 | -3800.0% | |
| 2023 | $0.01 | $0.01 | -96.7% | |
| 2022 | $0.30 | $1.05 | -11.8% | |
| 2021 | $0.34 | $1.53 | -2.9% | |
| 2020 | $0.35 | $1.29 | +9.4% | |
| 2019 | $0.32 | $1.84 | -36.0% | |
| 2018 | $0.50 | $1.83 | +35.1% | |
| 2017 | $0.37 | $1.18 | +37.0% | |
| 2016 | $0.27 | $1.02 | +8.0% | |
| 2015 | $0.25 | $0.87 | +8.7% | |
| 2013 | $0.23 | $0.90 | +0.0% | |
| 2012 | $0.23 | $0.86 | -71.3% | |
| 2011 | $0.80 | $0.81 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-03-31 | 2025-10-14 | 0001040130-25-000072 | SEC ↗ |
| 2024-03-31 | 2024-06-14 | 0001040130-24-000046 | SEC ↗ |
| 2023-03-31 | 2023-05-23 | 0001040130-23-000033 | SEC ↗ |
| 2022-03-31 | 2022-05-24 | 0001437749-22-013417 | SEC ↗ |
| 2021-03-31 | 2021-05-25 | 0001437749-21-013213 | SEC ↗ |
| 2020-03-31 | 2020-05-26 | 0001437749-20-011720 | SEC ↗ |
| 2019-03-31 | 2019-05-28 | 0001437749-19-010894 | SEC ↗ |
| 2018-03-31 | 2018-05-29 | 0001437749-18-010847 | SEC ↗ |
| 2017-03-31 | 2017-05-23 | 0001571049-17-005258 | SEC ↗ |
| 2016-03-31 | 2016-05-24 | 0001571049-16-015491 | SEC ↗ |
| 2015-03-31 | 2015-05-22 | 0001571049-15-004580 | SEC ↗ |
| 2014-03-31 | 2014-05-27 | 0001571049-14-002091 | SEC ↗ |
| 2013-03-31 | 2013-05-28 | 0001188112-13-001701 | SEC ↗ |
| 2012-03-31 | 2012-05-29 | 0001188112-12-001799 | SEC ↗ |
| 2011-03-31 | 2011-05-31 | 0000943440-11-000276 | SEC ↗ |
| 2010-03-31 | 2010-06-01 | 0000943440-10-000378 | SEC ↗ |
| 2009-03-31 | 2009-06-01 | 0000943440-09-000359 | SEC ↗ |
| 2008-03-31 | 2008-06-03 | 0000943440-08-000245 | SEC ↗ |
| 2007-03-31 | 2007-06-04 | 0000943440-07-000291 | SEC ↗ |
| 2006-03-31 | 2006-06-02 | 0000943440-06-000207 | SEC ↗ |